AGER and acute respiratory distress syndrome: The aim of the present randomised trial was to investigate the potential therapeutic roles of either recombinant sRAGE or a RAGE antagonist peptide (RAP) on AFC and to establish the main features of experimental ARDS in a piglet model of hydrochloric acid (HCl)-induced ARDS.